Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic

Simple item page
dc.contributor.authorLeonardo M. R. Ferreira
dc.contributor.authorMohammed A. Mostajo-Radji
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:15:56Z
dc.date.available2026-03-22T14:15:56Z
dc.date.issued2020
dc.descriptionCitaciones: 21
dc.identifier.doi10.1038/s41541-020-0209-2
dc.identifier.urihttps://doi.org/10.1038/s41541-020-0209-2
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45501
dc.language.isoen
dc.publisherNature Portfolio
dc.relation.ispartofnpj Vaccines
dc.sourceUniversidad Privada de Santa Cruz de la Sierra
dc.subjectCoronavirus disease 2019 (COVID-19)
dc.subjectLow and middle income countries
dc.subjectHuman immunodeficiency virus (HIV)
dc.subjectPandemic
dc.subjectMedicine
dc.subjectVirology
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
dc.subject2019-20 coronavirus outbreak
dc.subjectDeveloping country
dc.subjectConvalescent plasma
dc.titlePlasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic
dc.typearticle

Files

Collections

Artículo Científico Publicado